Human Metabolome Technologies, Inc. (6090)

Market cap
¥3.7B
P/E ratio
17.3x
Provides high-sensitivity analysis of metabolic compounds to pharmaceutical companies, research institutions, and manufacturers to support drug development and product testing.
Period EndPretax margin (%) YoY (%)
Jun 30, 202516.6-7.68%
Jun 30, 202417.9+0.21%
Jun 30, 202317.9-13.46%
Jun 30, 202220.7+290.82%
Jun 30, 20215.3-458.79%
Jun 30, 2020-1.5-97.17%
Jun 30, 2019-52.1+22.01%
Mar 31, 2019-42.7+167.53%
Mar 31, 2018-16+260.98%
Mar 31, 2017-4.4-51.42%
Mar 31, 2016-9.1+255.78%
Mar 31, 2015-2.6-361.82%
Mar 31, 20141-105.19%
Mar 31, 2013-18.8+105.64%
Mar 31, 2012-9.2
AI Chat